Conference: May 4-6
Expo: May 5-6
Gaylord Opryland Resort & Convention Center
Nashville, TN
Note: Session dates/times are subject to change.
|
Search / Filter
|
| Tuesday, May 05, 2026 |
Tuesday, May 05, 2026
5:00 PM - 9:00 PM CDT
|
Location: Upper Portico (Grand Ole Opry) |
Location: Upper Portico (Grand Ole Opry) |
2026050517:0021:00 000 | TUE, MAY 5 |
0FFFB84B-B75D-F011-8104-ED7CCB3A2628 |
||
| Monday, May 04, 2026 |
Monday, May 04, 2026
8:00 AM - 4:00 PM CDT
|
Biologics Summit: Bridging Excipient Standards with Raw and Starting Materials in Biologics
Speaker(s): Basak Clements, Biomatria Consulting Lili Belcastro, Bristol Myers Squibb Nigel Langley, gChem Örn Almarsson, Axelyf Andrew Schaefer, Eurofins BioPharma Product Testing Arthur Zeng, Johnson&Johnson Innovative Medicine Rachael Atlee, Akron Bio Antonio Scatena, Gateway Analytical Dawn Henke, Standards Coordinating BodyLocation: Ryman Studio 1-2 Sponsored by: Invitria MilliporeSigma gChem Sartorius |
Location: Ryman Studio 1-2 |
2026050408:0016:00 001 | MON, MAY 4 |
13FFB84B-B75D-F011-8104-ED7CCB3A2628 F3FEB84B-B75D-F011-8104-ED7CCB3A2628 26FFB84B-B75D-F011-8104-ED7CCB3A2628 0CFFB84B-B75D-F011-8104-ED7CCB3A2628 08FFB84B-B75D-F011-8104-ED7CCB3A2628 21FFB84B-B75D-F011-8104-ED7CCB3A2628 04FFB84B-B75D-F011-8104-ED7CCB3A2628 2BFFB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 F8FEB84B-B75D-F011-8104-ED7CCB3A2628 F9FEB84B-B75D-F011-8104-ED7CCB3A2628 FAFEB84B-B75D-F011-8104-ED7CCB3A2628 01FFB84B-B75D-F011-8104-ED7CCB3A2628 FFFEB84B-B75D-F011-8104-ED7CCB3A2628 FEFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||
| Wednesday, May 06, 2026 |
Wednesday, May 06, 2026
2:00 PM - 3:00 PM CDT
|
Safeguarding Against Diethylene Glycol Contamination: Lessons from Recent Outbreaks
Speaker(s): Matthew Dionne, Office of Manufacturing Quality, CDER, FDALocation: Ryman Hall Stage 1 |
Location: Ryman Hall Stage 1 |
2026050614:0015:00 000 | WED, MAY 6 |
15FFB84B-B75D-F011-8104-ED7CCB3A2628 F3FEB84B-B75D-F011-8104-ED7CCB3A2628 10FFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 F8FEB84B-B75D-F011-8104-ED7CCB3A2628 F9FEB84B-B75D-F011-8104-ED7CCB3A2628 FFFEB84B-B75D-F011-8104-ED7CCB3A2628 FEFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||
| Monday, May 04, 2026 |
Monday, May 04, 2026
4:15 PM - 5:00 PM CDT
|
Location: Ryman Hall Stage 1 |
Location: Ryman Hall Stage 1 |
2026050416:1517:00 000 | MON, MAY 4 |
15FFB84B-B75D-F011-8104-ED7CCB3A2628 F3FEB84B-B75D-F011-8104-ED7CCB3A2628 10FFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 F8FEB84B-B75D-F011-8104-ED7CCB3A2628 F9FEB84B-B75D-F011-8104-ED7CCB3A2628 FFFEB84B-B75D-F011-8104-ED7CCB3A2628 FEFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||
| Tuesday, May 05, 2026 |
Tuesday, May 05, 2026
3:00 PM - 4:00 PM CDT
|
Location: Ryman Hall Stage 1 |
Location: Ryman Hall Stage 1 |
2026050515:0016:00 000 | TUE, MAY 5 |
15FFB84B-B75D-F011-8104-ED7CCB3A2628 F3FEB84B-B75D-F011-8104-ED7CCB3A2628 10FFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 F8FEB84B-B75D-F011-8104-ED7CCB3A2628 F9FEB84B-B75D-F011-8104-ED7CCB3A2628 FFFEB84B-B75D-F011-8104-ED7CCB3A2628 FEFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||
| Wednesday, May 06, 2026 |
Wednesday, May 06, 2026
9:30 AM - 10:15 AM CDT
|
Digital Evolution in Pharma Development: From Traditional Methods to End-To-End Lab Data Automation
Speaker(s): Peter Freed, Roquette AmericaLocation: Ryman Hall Stage 1 |
Location: Ryman Hall Stage 1 |
2026050609:3010:15 001 | WED, MAY 6 |
14FFB84B-B75D-F011-8104-ED7CCB3A2628 F1FEB84B-B75D-F011-8104-ED7CCB3A2628 26FFB84B-B75D-F011-8104-ED7CCB3A2628 0BFFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 20FFB84B-B75D-F011-8104-ED7CCB3A2628 04FFB84B-B75D-F011-8104-ED7CCB3A2628 2AFFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 F7FEB84B-B75D-F011-8104-ED7CCB3A2628 02FFB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||
| Tuesday, May 05, 2026 |
Tuesday, May 05, 2026
1:25 PM - 1:45 PM CDT
|
Modernizing Excipient Supplier Qualification with AI, Digital Tools, and Risk-Based Quality Management
Speaker(s): Jennifer Minogue, Bristol Myers SquibbLocation: Ryman Hall Stage 1 |
Location: Ryman Hall Stage 1 |
2026050513:2513:45 001 | TUE, MAY 5 |
14FFB84B-B75D-F011-8104-ED7CCB3A2628 F3FEB84B-B75D-F011-8104-ED7CCB3A2628 26FFB84B-B75D-F011-8104-ED7CCB3A2628 0DFFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 20FFB84B-B75D-F011-8104-ED7CCB3A2628 04FFB84B-B75D-F011-8104-ED7CCB3A2628 2AFFB84B-B75D-F011-8104-ED7CCB3A2628 F5FEB84B-B75D-F011-8104-ED7CCB3A2628 F8FEB84B-B75D-F011-8104-ED7CCB3A2628 F9FEB84B-B75D-F011-8104-ED7CCB3A2628 FAFEB84B-B75D-F011-8104-ED7CCB3A2628 FFFEB84B-B75D-F011-8104-ED7CCB3A2628 FEFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||
| Tuesday, May 05, 2026 |
Tuesday, May 05, 2026
11:15 AM - 11:35 AM CDT
|
Reducing the Cost of Quality Through Third‑Party Excipient Certification
Speaker(s): Jon Gawlak, SGS North AmericaLocation: Ryman Hall Stage 1 |
Location: Ryman Hall Stage 1 |
2026050511:1511:35 001 | TUE, MAY 5 |
15FFB84B-B75D-F011-8104-ED7CCB3A2628 F2FEB84B-B75D-F011-8104-ED7CCB3A2628 26FFB84B-B75D-F011-8104-ED7CCB3A2628 0DFFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 20FFB84B-B75D-F011-8104-ED7CCB3A2628 04FFB84B-B75D-F011-8104-ED7CCB3A2628 2AFFB84B-B75D-F011-8104-ED7CCB3A2628 F7FEB84B-B75D-F011-8104-ED7CCB3A2628 F8FEB84B-B75D-F011-8104-ED7CCB3A2628 F9FEB84B-B75D-F011-8104-ED7CCB3A2628 FAFEB84B-B75D-F011-8104-ED7CCB3A2628 01FFB84B-B75D-F011-8104-ED7CCB3A2628 02FFB84B-B75D-F011-8104-ED7CCB3A2628 00FFB84B-B75D-F011-8104-ED7CCB3A2628 FFFEB84B-B75D-F011-8104-ED7CCB3A2628 FEFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||
| Tuesday, May 05, 2026 |
Tuesday, May 05, 2026
1:50 PM - 2:35 PM CDT
|
CDMO Perspectives on Excipient Selection: Navigating Customer Preferences and Supply Chain Challenges
Speaker(s): Gus LaBella, Mikart, LLCLocation: Ryman Hall Stage 1 |
Location: Ryman Hall Stage 1 |
2026050513:5014:35 001 | TUE, MAY 5 |
13FFB84B-B75D-F011-8104-ED7CCB3A2628 F2FEB84B-B75D-F011-8104-ED7CCB3A2628 26FFB84B-B75D-F011-8104-ED7CCB3A2628 0BFFB84B-B75D-F011-8104-ED7CCB3A2628 08FFB84B-B75D-F011-8104-ED7CCB3A2628 21FFB84B-B75D-F011-8104-ED7CCB3A2628 04FFB84B-B75D-F011-8104-ED7CCB3A2628 2BFFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F5FEB84B-B75D-F011-8104-ED7CCB3A2628 F8FEB84B-B75D-F011-8104-ED7CCB3A2628 F9FEB84B-B75D-F011-8104-ED7CCB3A2628 01FFB84B-B75D-F011-8104-ED7CCB3A2628 FFFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||
| Tuesday, May 05, 2026 |
Tuesday, May 05, 2026
11:40 AM - 12:00 PM CDT
|
FDA’s Emerging Oversight of Excipients in Compounding
Speaker(s): Theodore Sullivan, Quarles and BradyLocation: Ryman Hall Stage 1 |
Location: Ryman Hall Stage 1 |
2026050511:4012:00 000 | TUE, MAY 5 |
15FFB84B-B75D-F011-8104-ED7CCB3A2628 F3FEB84B-B75D-F011-8104-ED7CCB3A2628 0DFFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 F8FEB84B-B75D-F011-8104-ED7CCB3A2628 F9FEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||
| Wednesday, May 06, 2026 |
Wednesday, May 06, 2026
1:00 PM - 1:55 PM CDT
|
Is IPEC‑PQG GMP Up to the Task of Being the Foundational GMP for Excipients Worldwide?
Speaker(s): Irwin Silverstein, IBS Consulting in Quality LLC Mike Cassell, MLC GMP Quality Consulting, LLC. Iain Moore, EXCiPACT Charlotte McIlvaine, Univar Solutions Jennifer Putnam, PerrigoLocation: Ryman Hall Stage 1 |
Location: Ryman Hall Stage 1 |
2026050613:0013:55 001 | WED, MAY 6 |
13FFB84B-B75D-F011-8104-ED7CCB3A2628 F3FEB84B-B75D-F011-8104-ED7CCB3A2628 26FFB84B-B75D-F011-8104-ED7CCB3A2628 0EFFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 20FFB84B-B75D-F011-8104-ED7CCB3A2628 04FFB84B-B75D-F011-8104-ED7CCB3A2628 2AFFB84B-B75D-F011-8104-ED7CCB3A2628 F5FEB84B-B75D-F011-8104-ED7CCB3A2628 F7FEB84B-B75D-F011-8104-ED7CCB3A2628 F8FEB84B-B75D-F011-8104-ED7CCB3A2628 F9FEB84B-B75D-F011-8104-ED7CCB3A2628 FFFEB84B-B75D-F011-8104-ED7CCB3A2628 FEFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||
| Tuesday, May 05, 2026 |
Tuesday, May 05, 2026
10:20 AM - 10:40 AM CDT
|
Microbes in Pharmaceutical Excipients - What is Objectionable?
Speaker(s): Rick Jakober, Perritt Laboratories, Inc.Location: Ryman Hall Stage 1 |
Location: Ryman Hall Stage 1 |
2026050510:2010:40 001 | TUE, MAY 5 |
14FFB84B-B75D-F011-8104-ED7CCB3A2628 F3FEB84B-B75D-F011-8104-ED7CCB3A2628 26FFB84B-B75D-F011-8104-ED7CCB3A2628 0DFFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 20FFB84B-B75D-F011-8104-ED7CCB3A2628 04FFB84B-B75D-F011-8104-ED7CCB3A2628 2AFFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F5FEB84B-B75D-F011-8104-ED7CCB3A2628 F8FEB84B-B75D-F011-8104-ED7CCB3A2628 F9FEB84B-B75D-F011-8104-ED7CCB3A2628 00FFB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||
| Wednesday, May 06, 2026 |
Wednesday, May 06, 2026
11:15 AM - 12:00 PM CDT
|
Patient Safety: Inside and Outside of FDA
Speaker(s): Debra Pagano, Debra L. Pagano, FDA Consultants, LLCLocation: Ryman Hall Stage 1 |
Location: Ryman Hall Stage 1 |
2026050611:1512:00 001 | WED, MAY 6 |
14FFB84B-B75D-F011-8104-ED7CCB3A2628 F3FEB84B-B75D-F011-8104-ED7CCB3A2628 26FFB84B-B75D-F011-8104-ED7CCB3A2628 0BFFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 20FFB84B-B75D-F011-8104-ED7CCB3A2628 04FFB84B-B75D-F011-8104-ED7CCB3A2628 2AFFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F5FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 F8FEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||
| Tuesday, May 05, 2026 |
Tuesday, May 05, 2026
1:00 PM - 1:20 PM CDT
|
Location: Ryman Hall Stage 1 |
Location: Ryman Hall Stage 1 |
2026050513:0013:20 001 | TUE, MAY 5 |
15FFB84B-B75D-F011-8104-ED7CCB3A2628 F2FEB84B-B75D-F011-8104-ED7CCB3A2628 26FFB84B-B75D-F011-8104-ED7CCB3A2628 0DFFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 20FFB84B-B75D-F011-8104-ED7CCB3A2628 05FFB84B-B75D-F011-8104-ED7CCB3A2628 2AFFB84B-B75D-F011-8104-ED7CCB3A2628 F5FEB84B-B75D-F011-8104-ED7CCB3A2628 F8FEB84B-B75D-F011-8104-ED7CCB3A2628 F9FEB84B-B75D-F011-8104-ED7CCB3A2628 FBFEB84B-B75D-F011-8104-ED7CCB3A2628 01FFB84B-B75D-F011-8104-ED7CCB3A2628 02FFB84B-B75D-F011-8104-ED7CCB3A2628 FFFEB84B-B75D-F011-8104-ED7CCB3A2628 FEFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||
| Tuesday, May 05, 2026 |
Tuesday, May 05, 2026
9:30 AM - 10:15 AM CDT
|
USP’s Excipient Standards/Solutions for Injectables and their Critical Role for PLGs/PLGAs in Drug Formulations
Speaker(s): Peng Zhang, US PharmacopeiaLocation: Ryman Hall Stage 1 |
Location: Ryman Hall Stage 1 |
2026050509:3010:15 001 | TUE, MAY 5 |
14FFB84B-B75D-F011-8104-ED7CCB3A2628 F3FEB84B-B75D-F011-8104-ED7CCB3A2628 26FFB84B-B75D-F011-8104-ED7CCB3A2628 0BFFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 20FFB84B-B75D-F011-8104-ED7CCB3A2628 04FFB84B-B75D-F011-8104-ED7CCB3A2628 2AFFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 F8FEB84B-B75D-F011-8104-ED7CCB3A2628 F9FEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||
| Wednesday, May 06, 2026 |
Wednesday, May 06, 2026
10:20 AM - 10:40 AM CDT
|
Data Integrity Considerations when Auditing Excipient Suppliers II
Speaker(s): Lucien (Luc) Sergile, Jr., Eli Lilly and Company Michael Gauger, Eli Lilly and CompanyLocation: Ryman Hall Stage 1 |
Location: Ryman Hall Stage 1 |
2026050610:2010:40 001 | WED, MAY 6 |
15FFB84B-B75D-F011-8104-ED7CCB3A2628 F3FEB84B-B75D-F011-8104-ED7CCB3A2628 26FFB84B-B75D-F011-8104-ED7CCB3A2628 0DFFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 20FFB84B-B75D-F011-8104-ED7CCB3A2628 04FFB84B-B75D-F011-8104-ED7CCB3A2628 2AFFB84B-B75D-F011-8104-ED7CCB3A2628 F5FEB84B-B75D-F011-8104-ED7CCB3A2628 F8FEB84B-B75D-F011-8104-ED7CCB3A2628 FAFEB84B-B75D-F011-8104-ED7CCB3A2628 01FFB84B-B75D-F011-8104-ED7CCB3A2628 02FFB84B-B75D-F011-8104-ED7CCB3A2628 FFFEB84B-B75D-F011-8104-ED7CCB3A2628 FEFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||
| Tuesday, May 05, 2026 |
Tuesday, May 05, 2026
8:00 AM - 9:00 AM CDT
|
Excipients: The Unsung Heroes in Addressing Bioavailability and Quality Challenges
Speaker(s): Karunakar (Karu) Sukuru, Catalent Pharma SolutionsLocation: Ryman Hall Stage 1 |
Location: Ryman Hall Stage 1 |
2026050508:0009:00 001 | TUE, MAY 5 |
14FFB84B-B75D-F011-8104-ED7CCB3A2628 F1FEB84B-B75D-F011-8104-ED7CCB3A2628 26FFB84B-B75D-F011-8104-ED7CCB3A2628 10FFB84B-B75D-F011-8104-ED7CCB3A2628 08FFB84B-B75D-F011-8104-ED7CCB3A2628 21FFB84B-B75D-F011-8104-ED7CCB3A2628 04FFB84B-B75D-F011-8104-ED7CCB3A2628 2BFFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 F7FEB84B-B75D-F011-8104-ED7CCB3A2628 F9FEB84B-B75D-F011-8104-ED7CCB3A2628 FFFEB84B-B75D-F011-8104-ED7CCB3A2628 FEFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||
| Wednesday, May 06, 2026 |
Wednesday, May 06, 2026
8:00 AM - 9:00 AM CDT
|
FDA Perspective on Excipient Component Nomenclature and Excipient Composition
Speaker(s): Adchara Pongpeerapat, Office of Pharmaceutical Quality, CDER, FDALocation: Ryman Hall Stage 1 |
Location: Ryman Hall Stage 1 |
2026050608:0009:00 000 | WED, MAY 6 |
14FFB84B-B75D-F011-8104-ED7CCB3A2628 F3FEB84B-B75D-F011-8104-ED7CCB3A2628 10FFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 F8FEB84B-B75D-F011-8104-ED7CCB3A2628 F9FEB84B-B75D-F011-8104-ED7CCB3A2628 FFFEB84B-B75D-F011-8104-ED7CCB3A2628 FEFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||
| Monday, May 04, 2026 |
Monday, May 04, 2026
12:00 PM - 1:00 PM CDT
|
Location: Ryman Hall B1 |
Location: Ryman Hall B1 |
2026050412:0013:00 000 | MON, MAY 4 |
0FFFB84B-B75D-F011-8104-ED7CCB3A2628 |
||
| Tuesday, May 05, 2026 |
Tuesday, May 05, 2026
12:00 PM - 1:00 PM CDT
|
Location: Ryman Hall B1 |
Location: Ryman Hall B1 |
2026050512:0013:00 000 | TUE, MAY 5 |
0FFFB84B-B75D-F011-8104-ED7CCB3A2628 |
||
| Wednesday, May 06, 2026 |
Wednesday, May 06, 2026
12:00 PM - 1:00 PM CDT
|
Location: Ryman Hall B1 |
Location: Ryman Hall B1 |
2026050612:0013:00 000 | WED, MAY 6 |
0FFFB84B-B75D-F011-8104-ED7CCB3A2628 |
||
| Tuesday, May 05, 2026 |
Tuesday, May 05, 2026
10:20 AM - 10:40 AM CDT
|
Mitigating Nitrosamine Risks: An In Silico Approach to Identifying NDSRIs & Evaluating API-Excipient Interactions
Speaker(s): Jason Wood, BASFLocation: Ryman Hall Stage 2 |
Location: Ryman Hall Stage 2 |
2026050510:2010:40 001 | TUE, MAY 5 |
14FFB84B-B75D-F011-8104-ED7CCB3A2628 F1FEB84B-B75D-F011-8104-ED7CCB3A2628 26FFB84B-B75D-F011-8104-ED7CCB3A2628 0DFFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 21FFB84B-B75D-F011-8104-ED7CCB3A2628 05FFB84B-B75D-F011-8104-ED7CCB3A2628 2AFFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 F7FEB84B-B75D-F011-8104-ED7CCB3A2628 F9FEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||
| Wednesday, May 06, 2026 |
Wednesday, May 06, 2026
10:20 AM - 10:40 AM CDT
|
Role of Binder Properties in High Shear Wet Granulation: Impact on Granule and Tableting Performance
Speaker(s): Larry Walsh, BENEO GmbHLocation: Ryman Hall Stage 2 |
Location: Ryman Hall Stage 2 |
2026050610:2010:40 001 | WED, MAY 6 |
14FFB84B-B75D-F011-8104-ED7CCB3A2628 F1FEB84B-B75D-F011-8104-ED7CCB3A2628 27FFB84B-B75D-F011-8104-ED7CCB3A2628 0DFFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 20FFB84B-B75D-F011-8104-ED7CCB3A2628 04FFB84B-B75D-F011-8104-ED7CCB3A2628 2AFFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 F7FEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||
| Wednesday, May 06, 2026 |
Wednesday, May 06, 2026
9:30 AM - 10:15 AM CDT
|
Navigating the Application of Beta-Cyclodextrin in Protein-Based Drug Product Development: Challenges and Opportunities
Speaker(s): Haichen Nie, Teva PharmaceuticalsLocation: Ryman Hall Stage 2 |
Location: Ryman Hall Stage 2 |
2026050609:3010:15 001 | WED, MAY 6 |
14FFB84B-B75D-F011-8104-ED7CCB3A2628 F1FEB84B-B75D-F011-8104-ED7CCB3A2628 26FFB84B-B75D-F011-8104-ED7CCB3A2628 0BFFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 21FFB84B-B75D-F011-8104-ED7CCB3A2628 04FFB84B-B75D-F011-8104-ED7CCB3A2628 2BFFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 F7FEB84B-B75D-F011-8104-ED7CCB3A2628 F8FEB84B-B75D-F011-8104-ED7CCB3A2628 FFFEB84B-B75D-F011-8104-ED7CCB3A2628 FEFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||
| Tuesday, May 05, 2026 |
Tuesday, May 05, 2026
1:00 PM - 1:45 PM CDT
|
Location: Ryman Hall Stage 2 |
Location: Ryman Hall Stage 2 |
2026050513:0013:45 001 | TUE, MAY 5 |
14FFB84B-B75D-F011-8104-ED7CCB3A2628 F1FEB84B-B75D-F011-8104-ED7CCB3A2628 26FFB84B-B75D-F011-8104-ED7CCB3A2628 0BFFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 20FFB84B-B75D-F011-8104-ED7CCB3A2628 04FFB84B-B75D-F011-8104-ED7CCB3A2628 2AFFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 FAFEB84B-B75D-F011-8104-ED7CCB3A2628 01FFB84B-B75D-F011-8104-ED7CCB3A2628 02FFB84B-B75D-F011-8104-ED7CCB3A2628 00FFB84B-B75D-F011-8104-ED7CCB3A2628 FFFEB84B-B75D-F011-8104-ED7CCB3A2628 FEFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||
| Wednesday, May 06, 2026 |
Wednesday, May 06, 2026
11:15 AM - 12:00 PM CDT
|
Lipid Nanoparticles for Delivery of Nucleic Acid Therapy
Speaker(s): Mansoor Amiji, Northeastern UniversityLocation: Ryman Hall Stage 2 |
Location: Ryman Hall Stage 2 |
2026050611:1512:00 001 | WED, MAY 6 |
13FFB84B-B75D-F011-8104-ED7CCB3A2628 F1FEB84B-B75D-F011-8104-ED7CCB3A2628 26FFB84B-B75D-F011-8104-ED7CCB3A2628 0BFFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 20FFB84B-B75D-F011-8104-ED7CCB3A2628 04FFB84B-B75D-F011-8104-ED7CCB3A2628 2AFFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F5FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 F7FEB84B-B75D-F011-8104-ED7CCB3A2628 FFFEB84B-B75D-F011-8104-ED7CCB3A2628 FEFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||
| Tuesday, May 05, 2026 |
Tuesday, May 05, 2026
9:30 AM - 10:15 AM CDT
|
Mitigating Nitrosamine Risk Through Strategic Excipient Selection in Pharmaceutical Formulations
Speaker(s): Joe Zeleznik, IMCD US PharmaLocation: Ryman Hall Stage 2 |
Location: Ryman Hall Stage 2 |
2026050509:3010:15 001 | TUE, MAY 5 |
14FFB84B-B75D-F011-8104-ED7CCB3A2628 F1FEB84B-B75D-F011-8104-ED7CCB3A2628 26FFB84B-B75D-F011-8104-ED7CCB3A2628 0BFFB84B-B75D-F011-8104-ED7CCB3A2628 08FFB84B-B75D-F011-8104-ED7CCB3A2628 21FFB84B-B75D-F011-8104-ED7CCB3A2628 04FFB84B-B75D-F011-8104-ED7CCB3A2628 2BFFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 F8FEB84B-B75D-F011-8104-ED7CCB3A2628 F9FEB84B-B75D-F011-8104-ED7CCB3A2628 FFFEB84B-B75D-F011-8104-ED7CCB3A2628 FEFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||
| Tuesday, May 05, 2026 |
Tuesday, May 05, 2026
11:40 AM - 12:00 PM CDT
|
Reinventing Vitamins - The Untapped Potential as Versatile Excipients
Speaker(s): Fernanda Onofre, dsm-firmenichLocation: Ryman Hall Stage 2 |
Location: Ryman Hall Stage 2 |
2026050511:4012:00 001 | TUE, MAY 5 |
15FFB84B-B75D-F011-8104-ED7CCB3A2628 F1FEB84B-B75D-F011-8104-ED7CCB3A2628 26FFB84B-B75D-F011-8104-ED7CCB3A2628 0DFFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 20FFB84B-B75D-F011-8104-ED7CCB3A2628 04FFB84B-B75D-F011-8104-ED7CCB3A2628 2AFFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 F7FEB84B-B75D-F011-8104-ED7CCB3A2628 01FFB84B-B75D-F011-8104-ED7CCB3A2628 02FFB84B-B75D-F011-8104-ED7CCB3A2628 00FFB84B-B75D-F011-8104-ED7CCB3A2628 FFFEB84B-B75D-F011-8104-ED7CCB3A2628 FEFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||
| Tuesday, May 05, 2026 |
Tuesday, May 05, 2026
1:50 PM - 2:35 PM CDT
|
Silent Innovation: The Strategic Role of Excipients in Extending Product Lifecycle
Speaker(s): Debora Rezende, Indorama Ventures - IndovinyaLocation: Ryman Hall Stage 2 |
Location: Ryman Hall Stage 2 |
2026050513:5014:35 001 | TUE, MAY 5 |
14FFB84B-B75D-F011-8104-ED7CCB3A2628 F1FEB84B-B75D-F011-8104-ED7CCB3A2628 26FFB84B-B75D-F011-8104-ED7CCB3A2628 0BFFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 20FFB84B-B75D-F011-8104-ED7CCB3A2628 05FFB84B-B75D-F011-8104-ED7CCB3A2628 2AFFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F5FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 F7FEB84B-B75D-F011-8104-ED7CCB3A2628 00FFB84B-B75D-F011-8104-ED7CCB3A2628 FFFEB84B-B75D-F011-8104-ED7CCB3A2628 FEFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||
| Tuesday, May 05, 2026 |
Tuesday, May 05, 2026
11:15 AM - 11:35 AM CDT
|
Nitrosamine Mitigation through Excipient Design: The Role of Clean Excipient Matrices of MCC and SMCC
Speaker(s): Upendra Reddy, Chemfield Cellulose Pvt. Ltd.Location: Ryman Hall Stage 2 |
Location: Ryman Hall Stage 2 |
2026050511:1511:35 001 | TUE, MAY 5 |
14FFB84B-B75D-F011-8104-ED7CCB3A2628 F1FEB84B-B75D-F011-8104-ED7CCB3A2628 26FFB84B-B75D-F011-8104-ED7CCB3A2628 0DFFB84B-B75D-F011-8104-ED7CCB3A2628 08FFB84B-B75D-F011-8104-ED7CCB3A2628 21FFB84B-B75D-F011-8104-ED7CCB3A2628 04FFB84B-B75D-F011-8104-ED7CCB3A2628 2BFFB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 F7FEB84B-B75D-F011-8104-ED7CCB3A2628 F8FEB84B-B75D-F011-8104-ED7CCB3A2628 F9FEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||
| Monday, May 04, 2026 |
Monday, May 04, 2026
5:00 PM - 7:00 PM CDT
|
Location: Exhibit Hall (Ryman Hall B2-3) |
Location: Exhibit Hall (Ryman Hall B2-3) |
2026050417:0019:00 000 | MON, MAY 4 |
0FFFB84B-B75D-F011-8104-ED7CCB3A2628 |
||
| Tuesday, May 05, 2026 |
Tuesday, May 05, 2026
9:00 AM - 9:30 AM CDT
|
Location: Exhibit Hall (Ryman Hall B2-3) |
Location: Exhibit Hall (Ryman Hall B2-3) |
2026050509:0009:30 000 | TUE, MAY 5 |
14FFB84B-B75D-F011-8104-ED7CCB3A2628 11FFB84B-B75D-F011-8104-ED7CCB3A2628 |
||
| Wednesday, May 06, 2026 |
Wednesday, May 06, 2026
9:00 AM - 9:30 AM CDT
|
Location: Exhibit Hall (Ryman Hall B2-3) |
Location: Exhibit Hall (Ryman Hall B2-3) |
2026050609:0009:30 000 | WED, MAY 6 |
14FFB84B-B75D-F011-8104-ED7CCB3A2628 11FFB84B-B75D-F011-8104-ED7CCB3A2628 |
||
| Monday, May 04, 2026 |
Monday, May 04, 2026
1:00 PM - 4:00 PM CDT
|
From Powder to Product: Excipient Impact on Advanced Manufacturing
Speaker(s): Elizabeth Shen, Roquette Joe Zeleznik, IMCD US Pharma Brian Carlin, Carlin Pharma Consulting LLCLocation: Ryman Studio 16-18 |
Location: Ryman Studio 16-18 |
2026050413:0016:00 001 | MON, MAY 4 |
14FFB84B-B75D-F011-8104-ED7CCB3A2628 F1FEB84B-B75D-F011-8104-ED7CCB3A2628 26FFB84B-B75D-F011-8104-ED7CCB3A2628 0CFFB84B-B75D-F011-8104-ED7CCB3A2628 08FFB84B-B75D-F011-8104-ED7CCB3A2628 21FFB84B-B75D-F011-8104-ED7CCB3A2628 04FFB84B-B75D-F011-8104-ED7CCB3A2628 2BFFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F5FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 F8FEB84B-B75D-F011-8104-ED7CCB3A2628 01FFB84B-B75D-F011-8104-ED7CCB3A2628 FFFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||
| Monday, May 04, 2026 |
Monday, May 04, 2026
8:00 AM - 12:00 PM CDT
|
Risk Based Framework for Development of New Excipient Products and USP’s Novel Excipient Emerging Standards Approach to Meet Stakeholder Needs
Speaker(s): Meera Raghuram, Lubrizol David Schoneker, Black Diamond Regulatory Consulting, LLC Catherine Sheehan, USP Jenny Liu, US Pharmacopeia Ron Filler, Drug Development Consultants, LLC Claas Gronewold, EVONIK Health CareLocation: Ryman Studio 16-18 |
Location: Ryman Studio 16-18 |
2026050408:0012:00 001 | MON, MAY 4 |
15FFB84B-B75D-F011-8104-ED7CCB3A2628 F3FEB84B-B75D-F011-8104-ED7CCB3A2628 26FFB84B-B75D-F011-8104-ED7CCB3A2628 0CFFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 20FFB84B-B75D-F011-8104-ED7CCB3A2628 04FFB84B-B75D-F011-8104-ED7CCB3A2628 2AFFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 F8FEB84B-B75D-F011-8104-ED7CCB3A2628 F9FEB84B-B75D-F011-8104-ED7CCB3A2628 01FFB84B-B75D-F011-8104-ED7CCB3A2628 FEFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||
| Sunday, May 03, 2026 |
Sunday, May 03, 2026
5:00 PM - 7:00 PM CDT
|
Location: District Pavilion |
Location: District Pavilion |
2026050317:0019:00 000 | SUN, MAY 3 |
0FFFB84B-B75D-F011-8104-ED7CCB3A2628 |
Questions should be directed to Courtney Nazareno (571-814-3450).